A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of DP-R207 (Rosuvastatin 10mg
and Ezetimibe 10mg fixed dose combinations) in comparison to each component administered
alone in health male volunteers.